Screener
Mirum Pharmaceuticals, Inc. MIRM Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Holdback liabilities, current | 24,800 | — |
| Accrued expenses and other current liabilities | 174,561 | 196,185 |
| Total current liabilities | 222,788 | 205,799 |
| Operating lease liabilities, noncurrent | 10,465 | 7,516 |
| Convertible notes payable, net, noncurrent | 750,079 | 309,797 |
| Holdback liabilities, noncurrent | 61,154 | — |
| Other liabilities | 10,917 | 5,011 |
| Total liabilities | 1,055,403 | 528,123 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Mirum Pharmaceuticals, Inc.'s operating lease liabilities?
- Mirum Pharmaceuticals, Inc. (MIRM) reported operating lease liabilities of $10.47M in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s operating lease liabilities changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s operating lease liabilities increased by 32.7% year-over-year, from $7.88M to $10.47M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s operating lease liabilities?
- Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s operating lease liabilities has grown at a 23.4% compound annual growth rate (CAGR), from $2.63M to $7.52M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about Mirum Pharmaceuticals, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude